Funding shortfalls prompt re-prioritization of activities in Africa

Vaccination campaigns delayed or curtailed to minimize funding risk

After several rounds of intense vaccination campaigns to end a polio outbreak in west Africa, which saw heads of state, movie stars and football heroes advocate for the eradication of polio, funding shortfalls are forcing a reprioritization of further planned activities. Demand for oral polio vaccine (OPV) has recently gone up, following an outbreak in Tajikistan and resultant activity in that country and its neighbours. Together with the continued needs for supplementary immunization activities in West Africa, this demand has absorbed much of the flexible funding held for emergencies. While additional funds are expected later in the third quarter, activities planned for July and August in particular may require some adjustments.

Decisions to delay or curtail some activities are being made based on epidemiology, protecting activities in highest-risk areas (endemic countries and those with re-established transmission). In order to meet the first milestone in the new strategic plan for polio eradication (ending outbreaks which started in 2009), activities are now planned in June for Burkina Faso, Gambia, Guinea, Liberia, Mali, Mauritania and Senegal . On the other hand, Somalia and Ethiopia in the Horn of Africa (a region without a case since July 2009), may delay vaccination campaigns into later in the year. In the Democratic Republic of the Congo, campaigns in July may be cut to cover the highest-risk districts only. Partners in the Global Polio Eradication Initiative are examining every possible option to manage the cash flow and minimize any threat to progress made across the countries with importations of polio.


Related News

   14/09/2021
Update on polio eradication efforts in Pakistan for August 2021
   14/09/2021
GPEI joins the 5-year action journey to achieve irreversible progress towards gender equality
   27/08/2021
Three polio survivors from Mozambique, Congo and Ethiopia share their experiences of living with the effects of disease, and their hope for a polio-free world.
   27/08/2021
Learn how the type 2 novel oral polio vaccine (nOPV2) is being rolled out across Africa to help more sustainably address outbreaks of a non-wild form of polio, cVDPV2, and protect children across the continent.
   27/08/2021
Despite success against wild polio in the African region, outbreaks of the non-wild form of polio, cVDPV2, continue. With continued country commitment to eradication, a future where no child in Africa is paralysed by the virus is possible.